冷存全血血小板功能在失血性休克受伤儿童中得以保留
该研究纳入22例2岁及以上、体重10 kg及以上、失血性休克的受伤儿童,其中8例接受冷存低滴度抗A和抗B、去白细胞、O型全血(最多30 mL/kg),14例历史对照接受未交叉配血红细胞和传统室温血小板。输血后血小板计数(129 × 109/L vs. 135 × 109/L)和血栓弹力图最大振幅(59.5 mm vs. 60.2 mm)在两组间无显著差异;全血组体重调整血小板输注量中位数较低(2.4 mL/kg vs. 4.6 mL/kg,p=0.03)。死亡率、ICU住院时间、医院住院时间和呼吸机天数无显著差异。作者认为需更大队列确认这些发现。
要点
- 受伤儿童(≥2岁、≥10 kg)失血性休克接受冷存全血最多30 mL/kg后,输血后血小板计数129 × 109/L vs. 传统室温血小板组135 × 109/L,无显著差异。
- 血栓弹力图最大振幅在冷存全血组59.5 mm vs. 传统室温血小板组60.2 mm,无显著差异。
- 全血组体重调整血小板输注量中位数2.4 mL/kg vs. 历史对照组4.6 mL/kg(p=0.03)。
- 死亡率、ICU住院时间、医院住院时间和呼吸机天数在两组间无显著差异。
- 作者结论:严重受伤儿童接受冷存全血血小板与传统室温血小板相比,输血后血小板数量或功能无差异;需更大队列确认。
适用人群与场景
- 受伤儿童,2岁或以上且10 kg或以上,失血性休克,接受冷存全血初始复苏。
- 纳入条件:(1)接受全血且未接受传统血小板;(2)输血前后均测量血小板计数和血栓弹力图最大振幅。
处置流程与药物剂量
- 冷存全血为低滴度(<50)抗A和抗B、去白细胞、O型全血,初始复苏期间最多30 mL/kg。
研究设计与关键结果
- 研究类型:治疗性研究,证据等级IV;22例儿童,14例成分血对照队列 vs. 8例全血队列。
- 输血后血小板计数:全血组129 × 109/L vs. 成分血组135 × 109/L,无显著差异。
- 输血后血小板功能(血栓弹力图最大振幅):全血组59.5 mm vs. 成分血组60.2 mm,无显著差异。
- 体重调整血小板输注量中位数(四分位距):历史成分血队列4.6(2.5-7.7)mL/kg vs. 全血队列2.4(1.3-4.0)mL/kg(p=0.03)。
- 年龄、种族、受伤机制、损伤严重度评分、生命体征和严重创伤性脑损伤在两组间无差异。
- 死亡率、ICU住院时间、医院住院时间和呼吸机天数在两组间无显著差异。
证据类型、等级与局限
- 证据类型:治疗性研究,证据等级IV。
- 局限:作者指出需更大队列确认这些发现。
对床旁实践的改变
- 作者认为,严重受伤儿童接受冷存全血血小板与传统室温血小板相比,输血后血小板数量或功能无差异;需更大队列确认这些发现。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Recent data demonstrate the safety of uncrossmatched cold-stored whole blood (WB) transfusion in pediatric trauma patients. The hemostatic capabilities of platelets within the cold-stored WB unit have been demonstrated via in vitro studies and animal models. However, platelet function has not been evaluated in pediatric recipients of cold-stored WB transfusions.
METHODS: Injured children, 2 years or older and 10 kg or greater with hemorrhagic shock received up to 30 mL/kg of cold-stored, low titer (<50) anti-A and -B, leukoreduced, group O- WB during their initial resuscitation. Patients were included if (1) they received WB and no conventional platelets, and (2) platelet count and thromboelastography maximum amplitude were measured both before and after transfusion. These data and relevant clinical outcomes (mortality, intensive care unit length of stay [LOS], hospital LOS and ventilator days) were compared to a historical cohort of pediatric trauma patients who received uncrossmatched red blood cells (RBC) and conventional room temperature platelets.
RESULTS: Twenty-two children were included in the study; 14 in the component cohort versus 8 in the WB cohort. Neither posttransfusion platelet count (129 × 109/L vs. 135 × 109/L) nor function (thromboelastography maximum amplitude, 59.5 mm vs. 60.2 mm) differed significantly between children receiving cold-stored platelets within the WB unit versus children who received conventional warm platelets. Median (interquartile range) weight-adjusted platelet transfusion volume in the historical cohort was 4.6 (2.5-7.7) mL/kg vs. 2.4 (1.3-4.0) mL/kg in the WB cohort (p = 0.03). There was no difference between groups in age, race, mechanism of injury, Injury Severity Score, vital signs, and severe traumatic brain injury (TBI). Outcomes, including mortality, intensive care unit LOS, hospital LOS, and ventilator days, were not significantly different between groups.
CONCLUSION: No difference was seen in posttransfusion platelet number or function in severely injured children receiving cold-stored WB platelets as compared to those receiving conventional room temperature-stored platelets. Larger cohorts are required to confirm these findings.
LEVEL OF EVIDENCE: Therapeutic, level IV.
参考来源
- Leeper CM, Yazer MH, Cladis FP, et al. Cold-stored whole blood platelet function is preserved in injured children with hemorrhagic shock. J Trauma Acute Care Surg. 2019. PMID: 31033893. doi:10.1097/TA.0000000000002340
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。